InspireMD (NSPR) Net Margin Growth (3y) (2013 - 2025)
InspireMD (NSPR) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,018.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1,978.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 399.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | -193,292.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -193,292.00 |
| Sep 30, 2025 | -20,079.00 |
| Jun 30, 2025 | -42,942.00 |
| Mar 31, 2025 | -37,073.00 |
| Dec 31, 2024 | -267,185.00 |
| Sep 30, 2024 | -8,740.00 |
| Jun 30, 2024 | -13,712.00 |
| Mar 31, 2024 | -16,830.00 |
| Dec 31, 2023 | 2.36 Mn |
| Sep 30, 2023 | -13,868.00 |
| Jun 30, 2023 | 47,002.00 |
| Mar 31, 2023 | -15,814.00 |
| Dec 31, 2022 | -21,944.00 |
| Sep 30, 2022 | -9,604.00 |
| Jun 30, 2022 | -13,988.00 |
| Mar 31, 2022 | 39,399.00 |
| Dec 31, 2021 | -1,844.00 |
| Sep 30, 2021 | -11,860.00 |
| Jun 30, 2021 | -23,477.00 |
| Mar 31, 2021 | -8,513.00 |